MOLOGEN AG receives approval for clinical study with cell-based gene therapy ... - PharmaLive.com (press release) PDF Print
PharmaLive.com (press release)MGN1601 is a cell-based gene therapy for the treatment of advanced renal cancer. The responsible ethics committee has also agreed to the execution of the

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.